{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:10:57Z","timestamp":1788433857247,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1124\/dmd.118.084624","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T21:45:15Z","timestamp":1548279915000},"page":"412-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Hepatocyte Concentrations of Imaging Compounds Associated with Transporter Inhibition: Evidence in Perfused Rat Livers"],"prefix":"10.1016","volume":"47","author":[{"given":"Pierre","family":"Bonnaventure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Cusin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1551-3824","authenticated-orcid":false,"given":"Catherine M.","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.118.084624_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/cpt.997","article-title":"Transporter-mediated alterations in patients with NASH increase systemic and hepatic exposure to an OATP and MRP2 substrate","volume":"104","author":"Ali","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.118.084624_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cpt.888","article-title":"Influence of OATPs on hepatic disposition of erlotinib measured with positron emission tomography","volume":"104","author":"Bauer","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.118.084624_bib3","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1021\/acs.molpharmaceut.8b00588","article-title":"Effect of rifampicin on the distribution of [11C]erlotinib to the liver, a translational PET study in humans and in mice","volume":"15","author":"Bauer","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.118.084624_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/jpet.113.203257","article-title":"Substrate-dependent ligand inhibition of the human organic cation transporter OCT2","volume":"346","author":"Belzer","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.118.084624_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11095-018-2524-0","article-title":"The Extended Clearance concept following oral and intravenous dosing: theory and critical analyses","volume":"35","author":"Benet","year":"2018","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.118.084624_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cpt.802","article-title":"The universally unrecognized assumption in predicting drug clearance and organ extraction ratio","volume":"103","author":"Benet","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.118.084624_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1258\/002367706777611460","article-title":"The isolated perfused rat liver: standardization of a time-honoured model","volume":"40","author":"Bessems","year":"2006","journal-title":"Lab Anim"},{"key":"10.1124\/dmd.118.084624_bib8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1083\/jcb.72.2.441","article-title":"Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study","volume":"72","author":"Blouin","year":"1977","journal-title":"J Cell Biol"},{"key":"10.1124\/dmd.118.084624_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/ijms16010135","article-title":"Quantification of drug transport function across the multiple resistance-associated protein 2 (Mrp2) in rat livers","volume":"16","author":"Bonnaventure","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1124\/dmd.118.084624_bib10","doi-asserted-by":"crossref","first-page":"7310146","DOI":"10.1155\/2018\/7310146","article-title":"Positron emission tomography imaging reveals an importance of saturable liver uptake transport for the pharmacokinetics of metoclopramide","volume":"2018","author":"Caill\u00e9","year":"2018","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1124\/dmd.118.084624_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/clpt.2013.78","article-title":"Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver","volume":"94","author":"Chu","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.118.084624_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/bcpt.12671","article-title":"Hepatocyte concentrations of Indocyanine Green reflect transfer rates across membrane transporters","volume":"120","author":"Cusin","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/dmd.118.084624_bib13","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1124\/dmd.113.051870","article-title":"Evidence of drug-drug interactions through uptake and efflux transport systems in rat hepatocytes: implications for cellular concentrations of competing drugs","volume":"41","author":"Daali","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084624_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s13318-016-0382-x","article-title":"Liver perfusion modifies Gd-DTPA and Gd-BOPTA hepatocyte concentrations through transfer clearances across sinusoidal membranes","volume":"42","author":"Daire","year":"2017","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.118.084624_bib15","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jhep.2010.07.047","article-title":"Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green","volume":"54","author":"de Graaf","year":"2011","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.118.084624_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/clpt.2012.240","article-title":"Intracellular drug concentrations","volume":"93","author":"Dollery","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.118.084624_bib17","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s11095-008-9597-0","article-title":"Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies","volume":"25","author":"Ghibellini","year":"2008","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.118.084624_bib18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cpt.1183","article-title":"Advancing predictions of tissue and intracellular drug concentrations using in vitro, imaging and physiologically based pharmacokinetic modeling approaches","volume":"104","author":"Guo","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.118.084624_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/dmd.114.059105","article-title":"Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions","volume":"43","author":"Izumi","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084624_bib20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1124\/dmd.118.080408","article-title":"A clinical quantitative evaluation of hepatobiliary transport of [11C]dehydropravastatin in humans using positron emission tomography","volume":"46","author":"Kaneko","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084624_bib21","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1021\/jm300212s","article-title":"Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions","volume":"55","author":"Karlgren","year":"2012","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.118.084624_bib23","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/00498254.2017.1393582","article-title":"Substrate-dependent effects of molecular-targeted anticancer agents on activity of organic anion transporting polypeptide 1B1","volume":"48","author":"Koide","year":"2018","journal-title":"Xenobiotica"},{"issue":"Suppl 7","key":"10.1124\/dmd.118.084624_bib24","first-page":"S143","article-title":"Use of PET imaging to evaluate transporter-mediated drug-drug interactions","volume":"56","author":"Langer","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.118.084624_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/CS20171131","article-title":"Quantification of hepatic perfusion and hepatocyte function with dynamic gadoxetic acid-enhanced MRI in patients with chronic liver disease","volume":"132","author":"Leporq","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"10.1124\/dmd.118.084624_bib26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1124\/jpet.113.204206","article-title":"Substrate-dependent inhibition of human MATE1 by cationic ionic liquids","volume":"346","author":"Mart\u00ednez-Guerrero","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.118.084624_bib27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/jpet.110.175406","article-title":"How organic anions accumulate in hepatocytes lacking Mrp2: evidence in rat liver","volume":"336","author":"Millet","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.118.084624_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0022-4804(92)90028-X","article-title":"An improved technique for isolated perfusion of rat livers and an evaluation of perfusates","volume":"53","author":"Mischinger","year":"1992","journal-title":"J Surg Res"},{"key":"10.1124\/dmd.118.084624_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2967\/jnumed.112.108233","article-title":"In vivo visualization and quantification of (Disturbed) Oatp-mediated hepatic uptake and Mrp2-mediated biliary excretion of 99mTc-mebrofenin in mice","volume":"54","author":"Neyt","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1124\/dmd.118.084624_bib30","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1164\/ajrccm.157.3.9609119","article-title":"Oxygen supply dependence of urea production in the isolated perfused rat liver","volume":"157","author":"Pastor","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/dmd.118.084624_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/cpt.437","article-title":"Transport vs. metabolism: what determines the pharmacokinetics and pharmacodynamics of drugs? Insights from the Extended Clearance Model","volume":"100","author":"Patilea-Vrana","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.118.084624_bib32","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1124\/dmd.118.081307","article-title":"When does the rate-determining step in the hepatic clearance of a drug switch from sinusoidal uptake to all hepatobiliary clearances? Implications for predicting drug-drug interactions","volume":"46","author":"Patilea-Vrana","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.118.084624_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejps.2017.03.002","article-title":"Substrate and method dependent inhibition of three ABC-transporters (MDR1, BCRP, and MRP2)","volume":"103","author":"Pedersen","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.118.084624_bib34","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1038\/psp.2012.21","article-title":"Effect of ritonavir on (99m)Technetium-mebrofenin disposition in humans: a semi-PBPK modeling and in vitro approach to predict transporter-mediated DDIs","volume":"2","author":"Pfeifer","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1124\/dmd.118.084624_bib35","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1124\/mol.106.030759","article-title":"Function of both sinusoidal and canalicular transporters controls the concentration of organic anions within hepatocytes","volume":"71","author":"Planchamp","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.118.084624_bib36","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s11095-010-0203-x","article-title":"Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytes","volume":"27","author":"Swift","year":"2010","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.118.084624_bib37","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2967\/jnumed.111.098681","article-title":"PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me","volume":"53","author":"Takashima","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1124\/dmd.118.084624_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/jpet.102.043026","article-title":"Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation","volume":"304","author":"Tirona","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.118.084624_bib39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pharmthera.2018.04.006","article-title":"Imaging techniques to study drug transporter function in vivo","volume":"189","author":"Tournier","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.118.084624_bib40","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10928-010-9176-y","article-title":"Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans","volume":"37","author":"Watanabe","year":"2010","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/dmd.118.084624_bib41","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/clpt.2011.351","article-title":"Transporter-mediated drug-drug interactions involving OATP substrates: predictions based on in vitro inhibition studies","volume":"91","author":"Yoshida","year":"2012","journal-title":"Clin Pharmacol Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624079194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624079194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.118.084624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:58:11Z","timestamp":1739905091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624079194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0090955624079194"],"URL":"https:\/\/doi.org\/10.1124\/dmd.118.084624","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocyte Concentrations of Imaging Compounds Associated with Transporter Inhibition: Evidence in Perfused Rat Livers","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.118.084624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}